Skip to content

Patel Sanj K

Reporting owner on Forms 3, 4 and 5, CIK 1532218.

Patel Sanj K reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-06.

Issuers

IssuerRoles in the latest filingFilingsLast filed
KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430director, officer (CHAIRMAN & CEO)22026-11-06

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04M exercised+145,763$17.92925,800Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04S sold-1,460$92.35924,340Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04S sold-11,335$93.54913,005Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04S sold-81,742$94.2831,263Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04S sold-29,845$95.48801,418Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-04S sold-26,918$96.05774,500Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding 92,348Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding 109,795Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-04M exercised-145,763$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03M exercised+89,089$8.83958,970Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03M exercised+41,237$17.921,000,207Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03S sold-1,214$90.77998,993Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03S sold-68,664$92.7930,329Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03S sold-145,708$93.53784,621Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-03S sold-4,584$94.25780,037Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-03M exercised-89,089$00Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-03M exercised-41,237$0145,763Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02M exercised+53,381$8.83959,314Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-38,364$91.03920,950Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-24,188$91.83896,762Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-26,781$93.06869,981Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-11-02S sold-100$93.97869,881Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-11-02M exercised-53,381$089,089Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30M exercised+47,530$8.83999,324Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-41,169$92.01958,155Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-18,685$92.77939,470Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-15,903$93.62923,567Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-8,888$94.72914,679Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-4,490$95.97910,189Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-2,316$97.34907,373Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share2026-10-30S sold-1,440$98.16905,933Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding 76,174Form 4
KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding 109,795Form 4
KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative2026-10-30M exercised-47,530$0142,470Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001532218-26-000020 Kiniksa Pharmaceuticals International, plc2026-11-06
Form 4 0001532218-26-000018 Kiniksa Pharmaceuticals International, plc2026-11-03